Latest filing published 05 Feb 2016 for ENDOLOGIX INC /DE/.
Insider track record
No signal scores available.
Shari L. O'Quinn: trading record in brief
Shari L. O'Quinn has filed trades across 2 companies (mainly through SEC (Form 4)), most often in TriVascular Technologies, Inc. and Endologix Inc /DE/. The record holds 11 filings, for trades running from 3 February 2016 to 31 May 2017.
Sales make up the whole of the open-market record (1 sale). The totals do not cover 1 filing with an undisclosed amount. Outside the open market, there are 5 share grants and 2 option exercises.
Most recently, on 6 June 2017, the filings show a share grant in Endologix Inc /DE/. The median gap between a trade and its publication by SEC (Form 4) is 1 day. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Shari L. O'Quinn
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 39,841 sharesCommon SharesSEC:0001013606-16-000174:0
- 9,400 sharesCommon StockSEC:0001562180-16-001519:0
- 3,549 sharesCommon StockSEC:0001562180-16-001519:1
- 5,851 sharesCommon StockSEC:0001562180-16-001519:2
- 41,838 sharesCommon StockSEC:0001562180-16-001519:3
- 18,092 sharesCommon StockSEC:0001562180-16-001519:4
- 23,746 sharesCommon StockSEC:0001562180-16-001519:5
7 of 7 declarations
